US5935506A — Method for the manufacture of intraluminal stents…

Claim 1

Independent Claim 107 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising the following steps: preparing a viscous polymer solution of poly-β-hydroxybutanoic acid as a bioresorbable polymeric material in a solvent, successively coating a surface of a male mold core (2) with layers of the polymer solution in several steps by precipitation of the polymeric material by the solvent being evaporated and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up, drawing the stent blank (1) off the male mold core (2), and subsequently treating the stent blank (1) to finish the shaping of the stent.

Claim 2

Independent Claim 107 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising the following steps: preparing a viscous polymer solution of poly-β-hydroxybutanoic acid as a bioresorbable polymeric material in a solvent, successively coating a surface of a male mold core (2) with layers of the polymer solution in several steps by precipitation of the polymeric material by the solvent being evaporated and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up, drawing the stent blank (1) off the male mold core (2), and subsequently treating the stent blank (1) to finish the shaping of the stent.

Claim 3

Dependent Claim 57 words

A method according to claim 1, wherein for successively coating the male mold core (2) with layers of the polymer solution, the male mold core (2) is alternatively dipped for several times into the polymer solution and removed from the latter for the solvent to evaporate from the layer (9, 11, 12, 13) of polymer solution depositing.

Claim 4

Dependent Claim 76 words

A method according to claim 1, wherein for successively coating the male mold core (2) with layers of the polymer solution, the latter is poured over the male mold core (2) in several successive operations, the previously adhering layer (9, 11, 12, 13) of polymer solution, between each pouring operation, being at least partially dissolved by the subsequent layer (11, 12, 13) of polymer solution and the polymeric material being precipitated by evaporation of the solvent.

Claim 5

Dependent Claim 22 words

A method according to claim 1, wherein the male mold core (2) is rotated during the build-up of the stent blank (1).

Claim 6

Dependent Claim 37 words

A method according to claim 1, wherein preparing the polymer solution consists in dissolving in chloroform poly-β-hydroxybutanoic acid as a powder in a percentage of 2 to 3% by weight referred to the total quantity of solution.

Claim 7

Dependent Claim 20 words

A method according to claim 5, wherein dissolving takes place by stirring at temperatures ranging between 50 and 70° C.

Claim 8

Dependent Claim 34 words

A method according to claim 1, wherein for adjustment of the mechanical properties of the stent, a biocompatible plasticizer of a concentration of 5 to 50% by weight is added to the polymer solution.

Claim 9

Independent Claim 138 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising: preparing a viscous chloroform solution of poly-β-hydroxy-butanoic acid as a bioresorbable polymeric material, applying the chloroform solution of poly-β-hydroxy-butanoic acid directly to a surface of the male mold core (2), and successively coating with additional layers of the solution by precipitation of the polymeric material by evaporation of the chloroform and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up on said male mold surface, removing the stent blank (1) from the male mold core (2), and subsequently finishing the shaping of the stent; wherein prior to being coated with the solution, the male mold core (2) is coated with a biocompatible release agent (8), which is insoluble in chloroform, but soluble in other solvents.

Claim 10

Independent Claim 138 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising: preparing a viscous chloroform solution of poly-β-hydroxy-butanoic acid as a bioresorbable polymeric material, applying the chloroform solution of poly-β-hydroxy-butanoic acid directly to a surface of the male mold core (2), and successively coating with additional layers of the solution by precipitation of the polymeric material by evaporation of the chloroform and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up on said male mold surface, removing the stent blank (1) from the male mold core (2), and subsequently finishing the shaping of the stent; wherein prior to being coated with the solution, the male mold core (2) is coated with a biocompatible release agent (8), which is insoluble in chloroform, but soluble in other solvents.

Claim 11

Dependent Claim 35 words

A method according to claim 8, wherein the release agent used is a concentrated sugar solution, which is dissolved by distilled water before the stent blank (1) is drawn off the male mold core (2).

Claim 12

Dependent Claim 25 words

A method according to claim 1, wherein at least one of a pharmaceutical anticoagulant and a cell-proliferation-inhibiting agent (10) is added to the polymer solution.

Claim 13

Independent Claim 130 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising: preparing a viscous solution of poly-β-hydroxy-butanoic acid as a bioresorbable polymeric material in a solvent, successively coating a male mold core (2) with layers of the polymeric material in several steps by precipitation of the polymeric material by evaporation of the solvent and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up, removing the stent blank (1) from the male mold core (2), and subsequently finishing the shaping of the stent; wherein at least one of a pharmaceutical anticoagulant and a cell-proliferation-inhibiting agent (10) is added to the solution, and is incorporated in the volume of the stent homogeneously for continuous release during bioresorption of the stent.

Claim 14

Independent Claim 130 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising: preparing a viscous solution of poly-β-hydroxy-butanoic acid as a bioresorbable polymeric material in a solvent, successively coating a male mold core (2) with layers of the polymeric material in several steps by precipitation of the polymeric material by evaporation of the solvent and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up, removing the stent blank (1) from the male mold core (2), and subsequently finishing the shaping of the stent; wherein at least one of a pharmaceutical anticoagulant and a cell-proliferation-inhibiting agent (10) is added to the solution, and is incorporated in the volume of the stent homogeneously for continuous release during bioresorption of the stent.

Claim 15

Independent Claim 129 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising: preparing a viscous solution of poly-β-hydroxy-butanoic acid as a bioresorbable polymeric material in a solvent, successively coating a male mold core (2) with layers of the polymeric material in several steps by precipitation of the polymeric material by the evaporation of solvent and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up, removing the stent blank (1) from the male mold core (2), and subsequently finishing the shaping of the stent; wherein at least one of a pharmaceutical anticoagulant and a cell-proliferation-inhibiting agent (10) is added to the solution, and is spread in one or several layers (9) for continuous release during bioresorption of the stent.

Claim 16

Independent Claim 129 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising: preparing a viscous solution of poly-β-hydroxy-butanoic acid as a bioresorbable polymeric material in a solvent, successively coating a male mold core (2) with layers of the polymeric material in several steps by precipitation of the polymeric material by the evaporation of solvent and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up, removing the stent blank (1) from the male mold core (2), and subsequently finishing the shaping of the stent; wherein at least one of a pharmaceutical anticoagulant and a cell-proliferation-inhibiting agent (10) is added to the solution, and is spread in one or several layers (9) for continuous release during bioresorption of the stent.

Claim 17

Independent Claim 129 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising: preparing a viscous solution of poly-β-hydroxy-butanoic acid as a bioresorbable polymeric material in a solvent, successively coating a male mold core (2) with layers of the polymeric material in several steps by precipitation of the polymeric material by the evaporation of solvent and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up, and wherein particles (14) of at least one of silver and silver alloys are added to the solution for being incorporated as an X-ray contrast medium and inflammation-inhibiting agent into the volume of the stent, removing the stent blank (1) from the male mold core (2), and subsequently finishing the shaping of the stent.

Claim 18

Independent Claim 129 words

A method for the manufacture of intravascular stents of bioresorbable polymeric material, comprising: preparing a viscous solution of poly-β-hydroxy-butanoic acid as a bioresorbable polymeric material in a solvent, successively coating a male mold core (2) with layers of the polymeric material in several steps by precipitation of the polymeric material by the evaporation of solvent and by the layer previously precipitated being dissolved at least partially for a homogeneous stent blank (1) to build up, and wherein particles (14) of at least one of silver and silver alloys are added to the solution for being incorporated as an X-ray contrast medium and inflammation-inhibiting agent into the volume of the stent, removing the stent blank (1) from the male mold core (2), and subsequently finishing the shaping of the stent.

Claim 19

Dependent Claim 28 words

A method according to claim 1, wherein prior to the coating of the male mold core (2) with the polymer solution, the latter is filtered through a frit.

Claim 20

Dependent Claim 24 words

A method according to claim 1, wherein the stent blank (1) is subsequently treated by at least one of laser-beam cutting and water-jet cutting.

Claim 21

Dependent Claim 13 words

A method according to claim 7, wherein said biocompatible plasticizer is ethyl citrate.

Claim 22

Dependent Claim 21 words

A method according to claim 9, wherein ethyl citrate of a concentration of 5-50% by weight is added to the solution.

Claim 23

Dependent Claim 16 words

A method according to claim 8, wherein the release agent used is a concentrated glucosid solution.

Claim 24

Dependent Claim 130 words

A method according to claim 1, wherein said successively coating comprises applying a first coating of said polymer solution containing a biocompatible plasticizer and a pharmaceutical anticoagulant to form a first layer; after evaporation of solvent from said first layer, applying thereto a second solution of said polymer containing a biocompatible plasticizer to form a second layer integral with said first layer; after evaporation of solvent from said second layer, applying a third layer of said polymer solution containing a biocompatible plasticizer, said third layer optionally also containing particles of an x-ray contrast medium, thereby providing a third layer integral with said second layer; and, after evaporating solvent from said third layer, optionally applying a fourth layer of said polymer solution optionally containing particles of an x-ray contrast medium therein.

Claim 25

Dependent Claim 16 words

A method according to claim 19, comprising only three or four of said applications of coatings.

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	2002-08-09	2003-02-08	2003-08-10	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	2006-08-09	2007-02-08	2007-08-10	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	2010-08-09	2011-02-08	2011-08-10	$7700.00	Window Closed / Lapsed

Method for the manufacture of intraluminal stents of bioresorbable polymeric material

Abstract

Inventors

Bibliographic Details

Claims Analysis

References Cited (Backward Citations)

USPTO Annuity & Maintenance Windows

Assigned Categories & Tags

Assign Category Tag